Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Study of Circulating Levels of Glicentin [NA]

View source ↗

Summary

The document notes the completion of a clinical trial assessing circulating glicentin levels in ischemic bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Ischemia Bowel | NA | Status: COMPLETED